XML 29 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Segment Information
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note 9. Segment Information
 
The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.
 
The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended December 31, 2015 and 2014 were $1,826 and $2,112, respectively and for the six months ended December 31, 2015 and 2014 were $3,818 and $4,395, respectively.
 
Financial information relating to the three months ended December 31, 2015 and 2014 operations by business segment are as follows:
 
     
Sales, Net
   
Segment
                 
     
U.S.
   
International
           
Gross
           
Capital
 
     
Customers
   
Customers
   
Total
   
Profit (loss)
   
Depreciation
   
Expenditures
 
Contract Manufacturing
2015
 
$
8,077
 
 
$
1,814
 
 
$
9,891
 
 
$
842
 
 
$
55
 
 
$
176
 
 
2014
    7,636       2,006       9,642       1,134       69       23  
                                                   
Branded Proprietary Products
2015
 
 
84
 
 
 
3
 
 
 
87
 
 
 
(19
)
 
 
-
 
 
 
-
 
 
2014
    69       76       145       (76 )     -       -  
                                                   
                                                   
Other Nutraceutical Businesses
2015
 
 
426
 
 
 
9
 
 
 
435
 
 
 
152
 
 
 
1
 
 
 
-
 
 
2014
    473       30       503       198       1       -  
                                                   
Total Company
2015
 
 
8,587
 
 
 
1,826
 
 
 
10,413
 
 
 
975
 
 
 
56
 
 
 
176
 
 
2014
    8,178       2,112       10,290       1,255       70       23  
 
Financial information relating to the six months ended December 31, 2015 and 2014 operations by business segment are as follows:
 
     
Sales, Net
   
Segment
                 
     
U.S.
   
International
           
Gross
           
Capital
 
     
Customers
   
Customers
   
Total
   
Profit (loss)
   
Depreciation
   
Expenditures
 
Contract Manufacturing
2015
 
$
15,007
 
 
$
3,629
 
 
$
18,636
 
 
$
1,883
 
 
$
114
 
 
$
230
 
 
2014
    13,379       4,071       17,450       2,285       129       374  
                                                   
Branded Proprietary Products
2015
 
 
232
 
 
 
175
 
 
 
407
 
 
 
109
 
 
 
-
 
 
 
-
 
 
2014
    198       286       484       (70 )     1       1  
                                                   
                                                   
Other Nutraceutical Businesses
2015
 
 
802
 
 
 
14
 
 
 
816
 
 
 
298
 
 
 
1
 
 
 
1
 
 
2014
    900       38       938       341       1       -  
                                                   
Total Company
2015
 
 
16,041
 
 
 
3,818
 
 
 
19,859
 
 
 
2,290
 
 
 
115
 
 
 
231
 
 
2014
    14,477       4,395       18,872       2,556       131       375  
 
 
 
   
Total Assets as of
 
   
December 31,
   
June 30,
 
   
2015
   
2015
 
Contract Manufacturing
 
$
11,087
 
  $ 8,482  
                 
Branded Proprietary Products
 
 
1,325
 
    1,324  
                 
Other Nutraceutical Businesses
 
 
1,808
 
    1,817  
                 
Total Company
 
$
14,220
 
  $ 11,623